Warner Chilcott Sues Mylan Again Over Doryx ANDA
The complaint, filed Friday in the U.S. District Court for the District of New Jersey, claims Mylan's plans to make a generic Doryx in 150 mg delayed-release tablets infringes Warner Chilcott's patent for the drug.
The suit was filed in response to Mylan's abbreviated new drug application with the U.S. Food and Drug...
Already a subscriber? Click here to login